scanX
Home
Advanced Enzyme Tech

Advanced Enzyme Tech

355.80
+5.15
(1.47%)
Market Cap (₹ Cr.)
₹3,923
52 Week High
571.00
Book Value
₹118
52 Week Low
334.05
PE Ratio
26.66
PB Ratio
2.93
PE for Sector
44.98
PB for Sector
4.22
ROE
9.99 %
ROCE
13.35 %
Dividend Yield
1.45 %
EPS
₹13.30
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
16.68 %
Net Income Growth
31.86 %
Cash Flow Change
0.72 %
ROE
23.49 %
ROCE
25.71 %
EBITDA Margin (Avg.)
13.60 %

Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
31
37
36
37
39
42
42
56
45
52
60
61
55
62
54
58
60
60
67
70
62
74
81
73
74
67
65
76
73
79
83
85
137
97
95
96
140
79
Expenses
23
30
24
26
30
27
30
38
36
42
45
40
38
46
44
43
40
43
42
46
38
44
52
49
46
47
51
55
61
58
59
59
61
70
67
82
65
64
EBITDA
8
6
12
11
9
15
13
18
10
10
15
20
17
16
10
15
21
17
24
24
24
30
29
25
27
20
14
21
13
21
25
26
76
27
28
14
75
15
Operating Profit %
27 %
16 %
33 %
29 %
20 %
34 %
28 %
29 %
21 %
15 %
23 %
32 %
30 %
22 %
18 %
24 %
32 %
26 %
31 %
34 %
38 %
40 %
34 %
31 %
36 %
27 %
21 %
22 %
16 %
25 %
27 %
28 %
29 %
28 %
27 %
11 %
24 %
17 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
2
2
3
3
2
3
3
3
3
3
3
3
3
3
Interest
1
2
1
1
1
0
1
1
1
1
1
1
1
2
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
6
3
9
8
6
12
10
16
7
7
12
17
14
12
9
13
18
14
22
22
22
28
26
22
25
17
12
18
10
18
22
23
74
25
25
10
72
12
Tax
1
1
2
1
2
2
2
3
2
1
2
4
4
3
2
3
5
4
5
6
6
8
5
6
7
5
3
4
3
5
6
5
6
7
7
8
5
3
Net Profit
5
2
8
7
4
10
8
14
5
5
10
15
11
9
6
9
13
11
18
16
15
20
20
15
19
13
9
14
8
14
17
18
68
18
19
3
67
9
EPS in ₹
2.05
0.95
3.49
3.10
1.65
4.26
0.71
5.65
0.46
0.48
0.90
1.38
0.97
0.97
0.57
0.82
1.19
1.00
1.57
1.43
1.37
1.80
1.82
1.37
1.66
1.15
0.78
1.28
0.70
1.22
1.49
1.56
6.04
1.64
1.71
0.28
6.00
0.82
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
222
261
318
373
376
423
490
530
576
633
Fixed Assets
106
101
98
98
97
127
132
132
143
142
Current Assets
69
81
95
104
102
125
160
177
190
248
Capital Work in Progress
4
7
8
10
7
10
7
9
11
22
Investments
0
0
103
120
121
121
185
189
202
256
Other Assets
113
152
108
145
151
165
166
200
220
213
Total Liabilities
222
261
318
373
376
423
490
530
576
633
Current Liabilities
47
55
44
70
45
36
41
36
37
40
Non Current Liabilities
20
32
19
14
11
17
13
13
14
12
Total Equity
156
174
255
289
320
371
435
480
525
581
Reserve & Surplus
134
152
233
267
297
348
413
458
503
558
Share Capital
22
22
22
22
22
22
22
22
22
22
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
-0
-0
0
3
-1
12
-4
-8
Investing Activities
-7
-27
-55
-22
-2
-25
-70
-14
-42
-7
Operating Activities
33
22
21
23
35
46
84
37
50
56
Financing Activities
-27
4
34
-1
-34
-19
-16
-11
-12
-57
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
55.38 %
52.30 %
52.55 %
52.71 %
52.70 %
52.70 %
49.87 %
49.87 %
49.87 %
46.52 %
45.92 %
43.62 %
43.49 %
43.02 %
42.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
23.01 %
12.03 %
12.63 %
DIIs
7.29 %
8.23 %
8.32 %
8.50 %
6.46 %
6.05 %
5.36 %
5.64 %
5.73 %
7.59 %
5.84 %
5.42 %
7.56 %
8.08 %
8.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.51 %
14.31 %
15.31 %
14.87 %
15.21 %
15.14 %
13.37 %
13.43 %
13.28 %
14.23 %
15.28 %
15.90 %
15.43 %
16.42 %
16.04 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,878.00 4,53,462.30 40.45 49,887.20 12.06 9,648 27.34 63.88
Cipla
1,537.90 1,23,492.30 26.78 26,520.70 14.17 4,155 12.95 61.16
Mankind Pharma
2,901.90 1,18,862.60 56.33 10,615.60 19.57 1,942 28.89 61.47
Dr Reddys Laboratories
1,375.05 1,14,230.80 21.41 28,905.40 12.36 5,578 -9.47 67.19
Lupin
2,396.10 1,07,886.20 41.08 20,141.50 19.94 1,936 73.53 77.18
Zydus Life Science
990.75 97,987.10 22.90 19,831.50 13.82 3,831 14.57 55.74
Aurobindo Pharma
1,348.80 78,597.00 21.71 29,559.20 17.55 3,169 8.66 66.58
Alkem Laboratories
5,579.75 66,609.70 30.65 12,978.40 9.84 1,812 14.16 52.65
Glenmark Pharmaceuticals
1,639.35 45,559.30 - 12,653.10 6.58 -1,831 675.49 65.22
Biocon
373.25 44,278.10 31.77 15,621.20 35.25 1,298 -84.31 61.48

Corporate Action

Technical Indicators

RSI(14)
Neutral
38.51
ATR(14)
Volatile
13.42
STOCH(9,6)
Neutral
20.31
STOCH RSI(14)
Neutral
38.29
MACD(12,26)
Bullish
0.41
ADX(14)
Weak Trend
17.31
UO(9)
Bearish
45.66
ROC(12)
Downtrend And Accelerating
-8.04
WillR(14)
Neutral
-65.35
Bearish
3
Neutral
5
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.